Drug Type Small molecule drug |
Synonyms RO6806051 |
Target |
Action inhibitors |
Mechanism FABP4 inhibitors(fatty acid binding protein 4 inhibitors), FABP5 inhibitors(Fatty acid binding protein 5 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H19ClN6 |
InChIKeyFXEKONNOBJEKPB-UHFFFAOYSA-N |
CAS Registry1433901-75-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | Switzerland | 01 Oct 2016 |